El Cordyceps cuenta con el mayor volumen de estudios renales de todos los hongos que vendemos. Una revisión Cochrane evaluó 22 ensayos aleatorizados en 1746 personas con enfermedad renal crónica, donde los preparados de Cordyceps sinensis tomados junto con el tratamiento convencional se asociaron con niveles más bajos de creatinina sérica. El Cordyceps militaris, la especie que comercializamos, cuenta con un estudio menor en el mismo contexto. El Reishi es el compañero para la noche. Ambos son extractos de agua caliente 10:1, probados para contener al menos un 30 % de beta-D-glucanos.
Start here. No other mushroom comes close on this: a Cochrane review of 22 randomised trials, plus a trial on the exact species we sell.
The other half of the day. Reishi is the most-studied mushroom we sell and the traditional evening partner to a morning Cordyceps.
Guardar $13.99
Pack Día y Noche: Polvo de Cordyceps y Reishi para la recuperaciónCordyceps aumenta la energía y la resistencia durante el día, Reishi calma la tarde y favorece un sueño reparador. Los dos extremos de un mismo día. Ambos en polvo de extracto, 100 g cada...Energía diurnaRecuperaciónResiliencia diaria
$65.99
Guardar $12.99
Pack Día y Noche: Cápsulas de Cordyceps y Reishi para la recuperaciónCordyceps aumenta la energía y la resistencia durante el día, Reishi calma la tarde y favorece un sueño reparador. Los dos extremos de un día. Ambos en cápsulas, 120 cápsulas cada uno, 40...Energía diurnaRecuperaciónResiliencia diaria
$56.99Cordyceps militaris
Start here. No other mushroom comes close on this: a Cochrane review of 22 randomised trials, plus a trial on the exact species we sell.
Ganoderma lucidum
The other half of the day. Reishi is the most-studied mushroom we sell and the traditional evening partner to a morning Cordyceps.
What customers report. Individual experience varies; none of this is a clinical claim.
The largest body of kidney research on any mushroom, assessed by Cochrane, the most rigorous standard in evidence review. Twenty-two randomised trials covering 1,746 participants. In people with chronic kidney disease not on dialysis, Cordyceps preparations taken alongside conventional treatment were associated with lower serum creatinine across 14 studies, improved creatinine clearance across 6, and reduced 24-hour proteinuria across 4, plus higher haemoglobin and serum albumin. The reviewers called it potential promise and asked for better-designed trials to confirm it.
Cochrane Database of Systematic Reviews · 2014The trial that puts Cordyceps militaris, the species we sell, into this literature directly. Patients with chronic kidney disease took 100 mg daily of a cordycepin preparation from C. militaris or placebo for three months, alongside their usual care. Urinary protein fell by 36.7%, blood urea nitrogen by 12.5% and creatinine by 18.3%, and the lipid profile improved. Run by the nephrology department of a Chinese general hospital, and it carries a 2020 correction notice.
Oxidative Medicine and Cellular Longevity · 2019A second Cochrane review, this one on Cordyceps used as an adjuvant alongside standard immunosuppression in kidney transplant recipients, where it has been part of routine practice in China for years. Evidence that this is an established clinical use with real institutional history behind it, not a wellness trend.
Cochrane Database of Systematic Reviews · 2015The most recent pooled analysis, on a fermented Cordyceps preparation widely prescribed in China. Combined with conventional treatment it outperformed conventional treatment alone on kidney function measures, and the network pharmacology section maps the pathways involved. Evidence that this field is still active and still producing results a decade after the Cochrane review.
Frontiers in Pharmacology · 2024Three weeks of daily supplementation was associated with a longer time to exhaustion, a higher ventilatory threshold and a higher VO2max; after one week, only time to exhaustion had improved. Read it for what it tested: the supplement was PeakO2, a six-species blend of mycelial biomass grown on oats, so nothing here is attributable to Cordyceps alone, and the three-week result comes from the 10 of 28 participants who continued that far. An encouraging early signal in a field that deserves a bigger trial.
Journal of Dietary Supplements · 2017Las otras opciones
Reishi
Read
